hexylresorcinol has been researched along with Nasopharyngeal Neoplasms in 1 studies
Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SG | 1 |
| Jeong, JH | 1 |
| Park, YW | 1 |
| Song, JY | 1 |
| Kim, AS | 1 |
| Choi, JY | 1 |
| Chae, WS | 1 |
1 other study available for hexylresorcinol and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Pro | 2011 |